SCHEMBL18907386

SCHEMBL18907386

C=Cc1ccc2c(-c3c4ccccc4c(-c4cc(-c5cccnc5)cc(-c5cccnc5)c4)c4ccccc34)nc3c4ccccc4ccc3c2c1C=C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.36
NPC1 O15118 3/20 0.36
RAB9A P51151 3/20 0.36
KMT2A Q03164 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 2/20 0.36
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
HTT P42858 1/20 0.36
CYP11B1 P15538 2/20 0.35
CYP19A1 P11511 2/20 0.35
CYP17A1 P05093 1/20 0.35
CYP11B2 P19099 1/20 0.35
CYP1A1 P04798 1/20 0.34
CYP1A2 P05177 1/20 0.34
PRKDC P78527 1/20 0.34
CYP1B1 Q16678 1/20 0.34
CYP2A6 P11509 1/20 0.33
ERN1 O75460 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18907214 0.79 KDM4E (0.47) KDM4ENPC1RAB9AKMT2AALDH1A1
SCHEMBL17034932 0.77 CYP2A6 (0.43) KDM4ENPC1RAB9AKMT2AALDH1A1
SCHEMBL20081042 0.72 CYP11B1 (0.53) KDM4ENPC1RAB9AKMT2AALDH1A1
SCHEMBL20089435 0.70 CYP11B1 (0.54) KDM4ENPC1RAB9AKMT2AALDH1A1
SCHEMBL17035066 0.70 CYP11B1 (0.43) KDM4ENPC1RAB9AKMT2AALDH1A1
SCHEMBL19770131 0.70 CYP19A1 (0.48) KDM4ENPC1RAB9AKMT2AALDH1A1
SCHEMBL19036109 0.70 ALDH1A1 (0.45) KDM4ENPC1RAB9AKMT2AALDH1A1
SCHEMBL20089434 0.69 CYP11B1 (0.62) KDM4ENPC1RAB9AKMT2AALDH1A1
SCHEMBL18907219 0.69 CYP11B1 (0.42) KDM4ENPC1RAB9AKMT2AALDH1A1
SCHEMBL16438150 0.68 KDM4E (0.56) KDM4ENPC1RAB9AKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170155057-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, OCIAD1, CCNT1 KDM4E 2914/4885NPC1 334/4885RAB9A 3042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.